帕唑帕尼联合治疗方案对一例FGFR3扩增胃腺癌的疗效
Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma.
作者信息
Limaye Sewanti, Patil Darshana, Akolkar Dadasaheb, Srivastava Navin, Patil Revati, Apurwa Sachin, Patil Sanket, John Jinumary, Gosavi Rahul, Nesargikar Prabhu, Kumar Prashant, Datta Vineet, Bose Chirantan, Raazi Zarrine, Srinivasan Ajay, Datar Rajan
机构信息
Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute Mumbai Maharashtra India.
Datar Cancer Genetics Nasik Maharashtra India.
出版信息
Clin Case Rep. 2021 Nov 7;9(11):e04986. doi: 10.1002/ccr3.4986. eCollection 2021 Nov.
Angiogenesis inhibitors (AGI) are not presently used for the treatment of gastric cancers. This report demonstrates that angiogenesis inhibitor can be safely and effectively used in combination with cytotoxic anti-cancer agents for treatment of Gastric cancers.
血管生成抑制剂（AGI）目前尚未用于治疗胃癌。本报告表明，血管生成抑制剂可与细胞毒性抗癌药物联合使用，安全有效地治疗胃癌。
Zotero 插件